Sartorius has unveiled the CellCelector CLD, an advanced automated platform designed to simplify and speed up monoclonal cell line development.
By integrating high-speed imaging, intelligent analysis, and gentle cell isolation, the system enables scientists to efficiently move from large candidate pools to the most promising clones with greater precision and confidence.
The technology streamlines early-stage workflows by rapidly identifying high-producing candidates, reducing both time and resource demands. Built-in monoclonality verification, combined with automated documentation, ensures full traceability throughout the process—supporting compliance and regulatory readiness from the outset.
With its high-throughput scanning capabilities, the CellCelector CLD can detect monoclonal wells and track clonal growth across extensive sample sets. When used alongside Sartorius’ Next Generation CLD Nanowell Plates, which offer the capacity of hundreds of standard plates, the platform significantly improves screening efficiency. Researchers can generate thousands of monoclonality-verified clones within just a few days, enabling faster progression to downstream development.
Selected clones are isolated using a gentle process that maintains up to 100% transfer efficiency and viability, preserving valuable cell lines for expansion. An integrated, compliance-ready productivity assay further ensures that every selection decision is fully documented and traceable.
As part of Sartorius’ comprehensive cell line development ecosystem, the CellCelector CLD brings together instruments, consumables, and reagents into a cohesive workflow. This integrated approach helps bioprocessing teams accelerate timelines, control costs, and meet stringent regulatory standards more effectively.
For more information, visit: https://sar.to/CellCelectorCDL
